Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BENDROFLUMETHIAZIDE Cause Atrioventricular block first degree? 10 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Atrioventricular block first degree have been filed in association with BENDROFLUMETHIAZIDE. This represents 1.0% of all adverse event reports for BENDROFLUMETHIAZIDE.

10
Reports of Atrioventricular block first degree with BENDROFLUMETHIAZIDE
1.0%
of all BENDROFLUMETHIAZIDE reports
0
Deaths
10
Hospitalizations

How Dangerous Is Atrioventricular block first degree From BENDROFLUMETHIAZIDE?

Of the 10 reports, 10 (100.0%) required hospitalization.

Is Atrioventricular block first degree Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BENDROFLUMETHIAZIDE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does BENDROFLUMETHIAZIDE Cause?

Hyponatraemia (332) Acute kidney injury (192) Confusional state (127) Hypotension (101) Vomiting (71) Dizziness (64) Hypokalaemia (64) Fall (60) Malaise (58) Agitation (57)

What Other Drugs Cause Atrioventricular block first degree?

FINGOLIMOD (285) AMLODIPINE (148) METOPROLOL (120) BISOPROLOL (98) FLECAINIDE (98) OMEPRAZOLE (94) AMIODARONE (85) VERAPAMIL (84) DILTIAZEM (79) FUROSEMIDE (78)

Which BENDROFLUMETHIAZIDE Alternatives Have Lower Atrioventricular block first degree Risk?

BENDROFLUMETHIAZIDE vs BENIDIPINE BENDROFLUMETHIAZIDE vs BENLYSTA BENDROFLUMETHIAZIDE vs BENRALIZUMAB BENDROFLUMETHIAZIDE vs BENSERAZIDE BENDROFLUMETHIAZIDE vs BENSERAZIDE\LEVODOPA

Related Pages

BENDROFLUMETHIAZIDE Full Profile All Atrioventricular block first degree Reports All Drugs Causing Atrioventricular block first degree BENDROFLUMETHIAZIDE Demographics